Medrx Co (TSE:4586) Cyclically Adjusted PS Ratio: (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4586 Medrx Co Ltd TSE:4586
62 GF Score
Price 円66.00
GF Value 円70.56
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Medrx Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medrx Co  (TSE:4586) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medrx Co Cyclically Adjusted PS Ratio Related Terms


Medrx Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medrx Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medrx Co Cyclically Adjusted PS Ratio Chart

Medrx Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 10.79 19.74 0.00 0.00

Medrx Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 8.95 8.83 0.00 0.00

TSE:4586 vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Cyclically Adjusted PS Ratio falls into.


TSE:4586
62GF Score
Medrx Co Ltd TSE:4586
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medrx Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medrx Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, Medrx Co's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0/113.0000*113.0000
=0.000

Current CPI (Dec. 2025) = 113.0000.

Medrx Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201509 2.973 98.500 3.411
201512 0.364 98.100 0.419
201603 1.388 97.900 1.602
201606 0.070 98.100 0.081
201609 1.378 98.000 1.589
201612 0.019 98.400 0.022
201703 2.120 98.100 2.442
201706 0.087 98.500 0.100
201709 0.091 98.800 0.104
201712 20.095 99.400 22.844
201803 0.026 99.200 0.030
201806 0.799 99.200 0.910
201809 0.000 99.900 0.000
201812 0.000 99.700 0.000
201903 1.801 99.700 2.041
201906 0.802 99.800 0.908
201909 10.947 100.100 12.358
201912 0.119 100.500 0.134
202003 0.000 100.300 0.000
202006 0.951 99.900 1.076
202009 0.000 99.900 0.000
202012 5.145 99.300 5.855
202103 0.381 99.900 0.431
202106 0.000 99.500 0.000
202109 0.037 100.100 0.042
202112 0.001 100.100 0.001
202203 0.080 101.100 0.089
202206 0.305 101.800 0.339
202209 0.000 103.100 0.000
202212 1.772 104.100 1.923
202303 0.230 104.400 0.249
202306 0.000 105.200 0.000
202309 0.582 106.200 0.619
202312 0.007 106.800 0.007
202403 0.000 107.200 0.000
202406 5.267 108.200 5.501
202412 0.000 110.700 0.000
202503 0.046 111.100 0.047
202506 0.338 111.700 0.342
202512 0.000 113.000 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medrx Co (TSE:4586) Overvalued in 2026?

Based on GuruFocus' analysis, Medrx Co stock appears to be undervalued. The current stock price of 円66.00 is trading 6.5% below its estimated GF Value™ of 円70.56. GuruFocus considers Medrx Co to be Fairly Valued.

Key valuation signals for TSE:4586:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円70.56 vs. price of 円66.00 (6.5% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the TSE:4586 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medrx Co Business Description

Address 431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.
62GF Score

Get the complete analysis for TSE:4586

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円66.00
Price
円70.56
GF Value